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Throughout life, stress stimuli act upon the brain leading to morphological and functional
changes in advanced age, when it is likely to develop neurodegenerative disorders.
There is an increasing need to unveil the molecular mechanisms underlying aging,
in a world where populations are getting older. Egr-1 (early growth response 1), a
transcriptional factor involved in cell survival, proliferation and differentiation – with a role
also in memory, cognition and synaptic plasticity, can be implicated in the molecular
mechanism of the aging process. Moreover, Heme Oxygenase-1a (HO), a 32 kDa
heat-shock protein that converts heme to iron, carbon monoxide and biliverdin, is a key
enzyme with neuroprotective properties. Several in vitro and in vivo studies reported that
HO-1 could regulate the metabolism of oxysterols, oxidation products of cholesterol that
include markers of oxidative stress. Recently, a link between Egr-1 and HO-1 has been
demonstrated in mouse lung cells exposed to cigarette smoke. In view of these data, we
wanted to investigate whether Egr-1 can be implicated also in the oxysterol metabolism
during brain aging. Our results show that Egr-1 expression is differently expressed in
the cortex and hippocampus of old mice, as well as the oxysterol profile between these
two brain areas. In particular, we show that the cortex experiences in an age-dependent
fashion increasing levels of the Egr-1 protein, and that these correlate with the level of
HO-1 expression and oxysterol abundance. Such a situation was not observed in the
hippocampus. These results are further strenghtened by our observations made with
Egr-1 KO mice, confirming our hypothesis concerning the influence of Egr-1 on oxysterol
production and accumulation via regulation of the expression of HO-1 in the cortex, but
not the hippocampus, of old mice. It is important to notice that most of the oxysterols
involved in this process are those usually stimulated by oxidative stress, which would
then represent the triggering factor for this mechanism.
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INTRODUCTION
Thanks to the efforts made in the past half century in preventing
diseases and improving patient conditions, the world population
is becoming older. This has certainly been a conquer for human
kind in general, but it also raises the question of whether we
have for the future to treat aging as a disease factor. In fact,
age is a recognized risk factor for adult-onset neurodegenerative
processes, including Alzheimer (AD) and Parkinson diseases
(PD) (Reitz et al., 2011; Reeve et al., 2014). How aging
affects from the molecular point of view the development of
neurodegenerative diseases still remains largely undefined.
Numerous studies have recognized Egr-1 as a gene influenced
by the aging process (Yau et al., 1996; Desjardins et al.,
1997; Blalock et al., 2003; Marrone et al., 2011). Egr-1 is an
immediate early gene coding for a zinc finger transcriptional
factor involved in cell differentiation, proliferation and survival.
Egr-1 expression, which is almost undetectable in mouse embryo
nervous system (McMahon et al., 1990), appears and slowly
increases in postnatal rat brains reaching consistent levels by
day 17 and from that it mantains baseline expression levels
until adulthood (Watson and Milbrandt, 1990; Beckmann and
Wilce, 1997). In the nervous system, this gene plays an important
role in memory and cognition, which are both affected in
advanced aging. Relevant changes in Egr-1 expression are
observed in rat brain during cortical and hippocampal synaptic
formation (Herms et al., 1994), favoring the hypothesis of an
involvement of Egr-1 in the regulation of plastic adaptation. In
agreement, mice lacking Egr-1 exhibit defects in durable long
term potentiation (LTP) and memory (Jones et al., 2001), and
Egr-1 is over-expressed in brains of AD patients and AD mouse
models (Bakalash et al., 2011; Hendrickx et al., 2013; Gatta
et al., 2014). Moreover, Egr-1 is involved in the phosphorylation
of tau protein as shown in experiments of Egr-1 deletion and
over-expression (Lu et al., 2011). Finally, Egr-1 is rapidly induced
by stress stimuli such as hypoxia, OS, brain injury, ischemic
stroke, and neuroinflammation (Beckmann et al., 1997; Yan
et al., 2000; Khachigian, 2006). OS plays an etiologic role in
brain aging, neurodegenerative and cardiovascular diseases, and
cancer (Thanan et al., 2014). In this context, we focused our
attention on HO-1, a 32 kDa heat-shock protein considered
as a new player in aging and neurodegenerative diseses (Chen
et al., 2003; Parfenova et al., 2012). In response to OS in the
brain, HO-1 is induced in neuronal and glial cells, the greater
HO-1 levels being observed within the astrocyte compartment
(Manganaro et al., 1995; Snyder et al., 1998). By converting heme
to iron, carbon monoxide and biliverdin (Chen and Regan, 2005),
HO-1 protects astrocytes against the heme-mediated oxidative
injury. On the other hand, HO-1 can also have neurotoxic effects
Abbreviations: 22-HC, 22-hydroxycholesterol; 24-HC, 24-hydroxycholesterol;
25-HC, 25-hydroxycholesterol; 27-HC, 27-hydroxycholesterol; 4α-HC,
4α-hydroxycholesterol; 4β-HC, 4β-hydroxycholesterol; 5α,6α-EC,
5α,6α-epoxycholesterol; 5β,6β-EC, 5β,6β-epoxycholesterol; 5α-OH,6-oxo-
CH, 5α-OH,6-5α-OH,6-oxocholesterol; 7α-HC, 7α-hydroxycholesterol; 7β-HC,
7β-hydroxycholesterol; 7-KC, 7-ketocholesterol; CA, Cornu Ammonis; CT,
5α-cholestane-3β,5,6β-triol; Cx, cortex; DG, Dentate Girus; Egr-1, Early growth
response-1; HO-1, heme oxygenase-1; Hp, hippocampus; KO, knock-out; OS,
oxidative stress; WT, wild-type.
depending on the balance between the free radical scavenging
properties of the produced biliverdin/bilirubin (Doré et al., 1999)
and the aggravated intracellular OS resulting from the free iron
formation (Zhang and Piantadosi, 1992). HO-1 expression has
not been rigourously localized in the human brain. In normal
conditions, HO-1 is scanty present in neuroglia and in some
neuron sub-populations from various brain areas, including
cortex and hippocampus (Vincent et al., 1994; Nakaso et al.,
2000).
Since the brain is the organ with the highest content
of cholesterol (approximately 20% of total body cholesterol
content), the role of sterols homeostasis and in particular
cholesterol metabolism, is of primary importance in the study
of aging related disorders. An interaction of HO-1 induction
with sterol regulation was reported both in in vitro and in vivo
studies (Vaya et al., 2007; Hascalovici et al., 2009, 2014). The aged
and neurodegenerated brain is constantly exposed to OS, which
leads to lipid peroxidation and to the generation of oxysterols
(Björkhem et al., 2002), oxygenated forms of cholesterol arising
also from OS (Iuliano, 2011). Oxysterols are able to induce
cytotoxicity and inflammation, worsening the neurodegeneration
process (Vaya and Schipper, 2007). Certain oxysterols are used to
control brain cholesterol levels, which is synthesized in situ and
unable to cross the blood brain barrier. A net flux of 24-HC from
the brain to the systemic circulation serves to export cholesterol
from the brain (Crick et al., 2015; Iuliano et al., 2015).
To prevent accumulation in the brain, cholesterol is oxidized
by the cytochrome p450 enzymes. During aging, it is the balanced
production of cholesterol and oxysterols to provide the basis for
oxysterol homeostasis in the brain. When this equilibrium is
perturbated, the accumulation of oxysterols in the brain can be
toxic. In AD patients the level of inflammatory molecules and the
expression of HO-1 were related to changes in oxysterols profile
and disease progression (Testa et al., 2016). A link between Egr-1
and HO-1 was reported in mouse lung cells exposed to cigarettes
smoke (Chen et al., 2010). With this work we have advanced
the hypothesis of a contribution of Egr-1 in the regulation of
oxysterol production in the aging brain. To test our hypothesis,
we studied the expression of Egr-1 and HO-1 in the cortex
and hippocampus of young, adult and aged WT and Egr-1 KO
mice, and measured the amount of oxysterols at tissue level. Our
results are consistent with the following outcome: Egr-1 regulates
oxysterols production by controlling the expression of HO-1.
This association is clearly present in the brain cortex but not in
the hippocampus, and it seems operative in an age-dependent
manner.
MATERIALS AND METHODS
Animals
Male C57BL/6 WT and Egr-1 KO mice aged 3, 12, and
24 months were used (n = 6 animals per strain and age).
Animals were housed 3 to 4 per cage, maintained under standard
temperature conditions (22◦C ± 2◦C) and 12-h:12-h light:dark
cycles. Throughout the study, they had access to food and water
ad libitum. All the experiments were performed in accordance
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with the EU Directive 2010/63/EU for animal experiments and
approved by ethic committee of Department of Medico-Surgical
Sciences and Biotechnologies, University of Roma “Sapienza”.
Brains Processing
For Western blot analysis and oxysterols determinations, mice
were sacrificed by cervical dislocation and the brains were
immediately removed and washed in ice cold Phosphate Buffer
Saline (PBS). Afterward, brains were divided into two emispheres
practicing a sagittal cut and both brain cortices and hippocampi
were accurately dissected, frozen on powdered dry ice, and
maintained at −80◦C until protein extraction and oxysterols
analysis.
For immunohistochemistry analysis, the whole brain was
extracted, washed in ice cold PBS and fixed for 24h at 4◦C with
Carnoy’s solution. Afterward, brains were mantained in 70%
ethanol untill the paraffin-embending process.
Immunohistochemistry
Immunohistochemical analysis was conducted as previously
described by our research group (Rosa et al., 2017), with
some modifications. In brief, paraffin-embedded tissues were
deparaffinized, rehydrated in descending graded alcohols,
incubated for 15 min in methanol containing 3% H2O2 to block
endogenous peroxidase activity, and then subjected to microwave
antigen retrieval for 30 min in sodium citrate buffer (10 mM
tri-sodium citrate dihydrate, 0.05% Tween-20, pH 6.0). After
preincubation in Super Block (ScyTek Laboratories, Logan, UT,
United States) for 10 min, sections were incubated overnight
with rabbit polyclonal anti-Egr-1 antibody (sc-110, Santa Cruz
Biotechnology, Dallas, TX, United States, dilution 1:100) or
rabbit polyclonal anti- HO-1 antibody (HO-1, sc-10789, Santa
Cruz Biotechnology, dilution 1:100) at 4◦C in humid chamber,
washed with PBS, incubated for 10 min at room temperature
with UltraTek Anti-Polyvalent (ScyTek Laboratories), washed
with PBS and then incubated with the UltraTek HRP (ScyTek
Laboratories) according to the manufacturer’s instructions. The
sections were then stained with 3-3-diaminobenzidine (ScyTek
Laboratories) as chromogen to visualize the reaction product,
and were finally counterstained with hematoxylin. Images were
acquired with Nikon Eclipse Ni motorized microscope system at
10× and 40×magnification.
Protein Extraction
Total protein extraction was performed homogenizing cortical
and hippocampal samples with a Teflon-glass potter in RIPA
buffer (50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1% Nonidet
P-40, 1 mM EDTA, 0.5% sodium deoxycholate, 0.1% SDS) with
protease inhibitors, 1 mM PMSF, 1mM DTT, and 0.5 mM sodium
orthovanadate (Sigma–Aldrich, St. Louis, MO, United States).
Protein concentration was determined by the Bradford assay
(Bio-Rad, Hercules, CA, United States).
Western Blot
Western blot analysis of brain extracts was carried out
as previously described (Ponti et al., 2015), with some
modifications. In brief, 40 µg of proteins per sample were
resolved on a 10% SDS–PAGE gel and blotted onto a PVDF
membrane (Amersham HyBond-P GE Healthcare, Chicago,
IL, United States). After blocking at room temperature in
5% dry-milk in PBS containing 0.1% Tween-20 for 1 h,
membranes were incubated overnight at 4◦C with rabbit
polyclonal anti-heme oxygenase 1 (HO-1, sc-10789, Santa
Cruz Biotechnology, dilution 1:500), rabbit polyclonal
anti-Egr-1 (sc-110, Santa Cruz Biotechnology, dilution
1:500), rabbit polyclonal anti-ERK1/2 (9102, Cell Signaling
Technology, Danvers, MA, United States dilution 1:1000),
mouse monoclonal anti-phospho-ERK1/2 (p-ERK1/2, 9106, Cell
Signaling Technology, dilution 1:1000) and mouse monoclonal
anti-β-actin (sc-47778, Santa Cruz Biotechnology, dilution
1:2000) antibody was used for normalization. Membranes were
then incubated with anti-rabbit and anti-mouse horseradish
peroxidase conjugated secondary antibodies (dilution 1:10000,
GE Healthcare Bio-Sciences, Piscataway, NJ, United States).
Immunocomplexes were detected by ECL Western Blotting
detection system (GE Healthcare Bio-Sciences). Digital images
were acquired using a ChemiDoc XRS + System (BioRad).
Band intensities were quantified by densitometric analysis using
Image Lab software (BioRad), and values were normalized to
β-actin.
Oxysterols and Cholesterol
Quantification
Cortical and hippocampal samples from 12 to 18 months
old WT and Egr-1 KO mice (n = 6 for each group) were
used for oxysterols determinations. In brief, oxysterols were
measured by isotope dilution mass spectrometry, essentially as
described elsewhere (Iuliano et al., 2003) with the exception
of the solid phase extraction (SPE) step, which was repeated
twice to eliminate cholesterol. Cholesterol discarded by elution
FIGURE 1 | Early growth response-1 and HO-1 expression in adult wild-type
mice cortex and hippocampus. Immunohistochemical analysis showing
representative brain sections from cortex (left images) and hippocampus (right
images) of adult wild-type (WT) mice stained with anti-Egr-1 (upper images)
and anti-HO-1 (bottom images) antibodies. Black arrows indicate strongly
positive signals. Images: 10× magnification, scale bars: 100 µm; inside
squares: 40× magnification, scale bars: 20 µm.
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FIGURE 2 | Different oxysterols profile between adult wild-type mice cortex and hippocampus. Isotope dilution mass spectrometry analysis showing oxysterols
levels in 12 months WT mice cortex (Cx, black bars) and hippocampus (Hp, gray bars) expressed as ng/mg of tissue. 7α-hydroxycholesterol (7α-HC),
7β-hydroxycholesterol (7β-HC), 7-ketocholesterol (7-KC), 5α,6α-epoxycholesterol (5α,6α-EC), 5β,6β-epoxycholesterol (5β,6β-EC), 4α-hydroxycholesterol (4α-HC),
4β-hydroxycholesterol (4β-HC), 5α-cholestane-3β,5,6β-triol (CT), 5α-OH,6-5α-OH,6-oxocholesterol (5α-OH,6-oxo-CH), 24-hydroxycholesterol (24-HC),
25-hydroxycholesterol (25-HC), 27-hydroxycholesterol (27-HC), 22-hydroxycholesterol (22-HC). Results are presented as the mean ± standard deviation (n = 6).
∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
from SPE was measured by isotope dilution mass spectrometry
such as oxysterols. Analyses were run on an Agilent 6890N gas
chromatograph equipped with a 7683 series automatic liquid
sampler, and interfaced with an Agilent 5973 mass spectrometer
(Agilent Technologies, Palo Alto, CA, United States). Separation
was achieved on a 30 m capillary column (HP-5MS 30
0.25 mm ID, 0.25 mm thickness). The mass spectrometer
was set to the selected ion monitoring mode; the molecules
were monitored with ions at mass/charge ratio (m/z): 463 m/z
for [2H7]-27-HC, [2H7]-24-HC, [2H7]-7α-HC, [2H7]-7β-HC,
[2H7]-4α-HC, [2H7]-4β-HC and [2H7]-cholesterol; 456 m/z
for [2H0]-27-HC, [2H0]-24-HC, [2H0]- 7α-HC, [2H0]-7β-HC,
[2H0]-4α- hydroxycholesterol (4α-HC), [2H0]-4β-HC and [2H0]-
cholesterol; 481 m/z for [2H7]-5α,6α-EC, and [2H7]-5β,6β-EC;
474 m/z for [2H0]-5α,6α-EC, and [2H0]-5β,6β-EC; 137 m/z
for [2H6]-25-HC, and 131 m/ z for [2H0]-25-HC; 479 m/z
for [2H7]-7-KC, and 472 m/z for [2H0]-7-KC; 478 m/z for
[2H6]-5α-OH,6-oxocholesterol and 472 m/z for [2H0]-5α-OH,6-
oxocholesterol (5α-OH,6-oxo-CH); 546 m/z for [2H7]-CT, and
552 m/ z for [2H0]-CT; 189 m/z for [2H7]- 22-HC and 181 m/z
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FIGURE 3 | Egr-1 protein expression in the cortex and hippocampus of young, adult and aged wild-type mice. Protein levels of Egr-1 in the cortex (A) and
hippocampus (B) of 3, 12 and 24 months old WT mice. The image shows representative western blots (upper panels) and bar graphs (bottom panels) obtained from
the relative densitometric analysis, as described in Materials and Methods. Results are presented as the mean ± standard deviation (n = 6). ∗∗∗p < 0.001.
for [2H0]- 22-HC. 5α-OH,6-oxo-CH, CT and theirs deuterated
were synthesized and kindly donated by Dr. Marc Poirot (Institut
Claudius Régaud, Toulouse, France). 4α-HC, 4β-HC and theirs
deuterated were kindly donated by Dr. G. Lizard (Faculté
des Sciences Gabriel, Dijon, France). All other oxysterols and
deuterated oxysterols were from Avanti Polar Lipids (Alabaster,
AL, United States). Quantification of oxysterols was assessed by
the internal standard ratio method.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism
software (La Jolla, CA, United States). Western blot results are
expressed as the mean ± standard deviation (SD) and statistical
comparisons were performed by Student’s t-test and one-way
analysis of variance (ANOVA). P-values < 0.05 were considered
significant.
RESULTS
Egr-1 and Heme Oxygenase-1 Have a
Different Distribution in the Brain Cortex
and Hippocampus of Adult Wild-Type
Mice
Among the brain areas involved in memory and cognition,
cortex and hippocampus are exposed to morphological and
functional changes as age advances. First of all we wanted
to compare the pattern of expression of Egr-1 and HO-1
in cortex and hippocampus of adult WT mice. They were
stained by immunohistochemistry on paraffin-embedded
sections. Figure 1 shows Egr-1 in the brain cortex with its
typical nuclear localization, and in the hippocampus within
the pyramidal neurons of CA (CA1-CA2-CA3-CA4) but not
in the DG. On the other hand, a weak presence of HO-1 was
detected in the cortex and hippocampus areas, mainly around
vessels.
Oxysterols Have Different Profiles in the
Brain Cortex and Hippocampus of
Wild-Type Mice
Extensive OS and oxysterol production are emerging
components of the neurodegenerative processes involved in
brain aging (Sottero et al., 2009). In order to get an oxysterol
profile for the cortex and hippocampus of adult WT mice,
we investigated the production of 13 different oxysterols. As
shown in Figure 2, the oxysterols included in our panel were
five of non-enzyimatic origin (7-KC, 7β-HC, 5α-OH,6-oxo-CH,
5α,6α-EC, and 5β,6β-EC), five of enzimatic origin (4β-HC,
4α-HC, 24-HC, 27-HC, and 22-HC), and three of both enzymatic
and non-enzymatic origin (25-HC, CT and 7α-HC). The
cortex and hippocampus showed distinct oxysterol profiles.
The hippocampus was characterized by higher levels of
oxysterol 7α-HC, 7β-HC, 7-KC, 5α,6α-EC, 5β,6β-EC, CT,
5α-OH,6-oxo-CH and 22-HC, whereas the cortex had higher
levels of 24-HC, 25-HC and 27-HC. 4α-HC and 4β-HC
were similarly distributed between cortex and hippocampus.
Cholesterol levels (Supplementary Figure S1) measured in the
same regions did not result in significant difference in the two
brain areas of both WT and KO mice, either at 12 and 18 months
of age.
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FIGURE 4 | ERK1/2 phosphorylation and HO-1 protein expression in the cortex of adult and aged wild-type and Egr-1 KO mice. ERK1/2, p-ERK1/2 and
HO-1protein levels in the cortex of 12 and 18 months old WT (A–C) and Egr-1 KO (B–D) mice. The image shows representative western blots (upper panels) and
bar graphs (bottom panels) obtained from the relative densitometric analysis, as described in Materials and Methods. Results are presented as the mean ± standard
deviation (n = 6). ∗p < 0.05; ∗∗∗p < 0.001.
Egr-1 Protein Expression Increases in
the Cortex but Not in the Hippocampus
During Aging of Wild-Type Mice
In order to advance the hypothesis of whether Egr-1 is involved
in oxysterol metabolism changes in brain aging, we checked
the levels of Egr-1 protein expression by western blot in the
brain cortex (Figure 3A) and hippocampus (Figure 3B) of young
(3 months), adult (12 months) and aged (24 months) WT mice.
Egr-1 levels were found to increase 1.4 folds from three to
12 months and 1.8 folds up to 24 months. These changes were
observed only in the cortex, suggesting a possible role of Egr-1
for cortex aging.
Egr-1 Is Sustained by ERK1/2
Phosphorylation and Is Likely Involved in
the Heme Oxygenase-1 Regulation in the
Brain Cortex of Aged Wild-Type Mice,
but Not in the Hippocampus
It has been reported that HO-1 is involved in oxysterol
metabolism during neurodegeneration (Leoni, 2009;
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FIGURE 5 | ERK1/2 phosphorylation and HO-1 protein expression in the hippocampus of adult and aged wild-type and Egr-1 KO mice. ERK1/2, p-ERK1/2 and
HO-1 protein levels in the hippocampus of 12 and 18 months old WT (A–C) and Egr-1 KO (B–D) mice. The image shows representative western blots (upper panels)
and bar graphs (bottom panels) obtained from the relative densitometric analysis, as described in Materials and Methods. Results are presented as the
mean ± standard deviation (n = 6).
Schipper et al., 2009). It has been also shown that Egr-1
regulates HO-1 expression induced by cigarette smoke in
mouse lung cells (Chen et al., 2010). Furthermore, the Egr-1
promoter has been described to be activated by the extracellular
signal-regulated kinase (ERK) 1/2, which has been documented
to be phosphorylated by many stress stimuli, including OS
(Park and Koh, 1999; Hartney et al., 2011; Chen et al., 2012).
Based on these observations, we compared by western blot the
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FIGURE 6 | Oxysterols levels in aged wild-type and Egr-1 KO mice brain cortex. Isotope dilution mass spectrometry analysis showing oxysterols levels in 18 months
wild-type (WT, black bars) and Egr-1 knock-out (KO, gray bars) mice cortex (Cx) expressed as ng/mg of tissue. 7α-HC, 7β-HC, 7-KC, 5α,6α-EC, 5β,6β-EC, 4α-HC,
4β-HC, CT, 5α-OH,6-oxo-CH, 24-HC, 25-HC, 27-HC, 22-HC. Results are presented as the mean ± standard deviation (n = 6). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
levels of ERK1/2 phosphorylation (Figures 4A,B) and HO-1
(Figures 4C,D) expression in the cortex of adult (12 months)
and aged (18 months) WT (Figures 4A–C) and Egr-1 KO
(Figures 4B–D) mice. Our results show that in WT mice the
phosphorylation of ERK1/2 and HO-1 expression are the highest
in the cortex of 18 months old mice, where also the Egr-1
levels are highest. In contrast, HO-1 expression is significantly
reduced in the cortex of age-matched Egr-1 KO mice, although
the stronger phosphorylation of ERK1/2. Similar experiments
to assay in the hippocampus the link between Egr-1 and HO-1
were performed. No statistically significant differences between
the levels of ERK1/2 phosphorylation (Figures 5A,B) and
the expression of HO-1 (Figures 5C,D) in the hippocampus
of adult and aged WT (Figures 5A–C) and Egr-1 KO mice
(Figures 5B–D) were observed.
Egr-1 Expression Is Pivotal to the
Oxysterol Production in the Brain Cortex
of Aged Wild-Type Mice
Thereafter, we were asking whether the correlation found
between the Egr-1 and HO-1 expression levels in the cortex of
aging mice were reflected also in a change of oxysterol levels. We
then compared the oxysterol levels in the old WT brain cortex
Frontiers in Aging Neuroscience | www.frontiersin.org 8 November 2018 | Volume 10 | Article 363
fnagi-10-00363 November 3, 2018 Time: 18:56 # 9
Rosa et al. Egr-1 and Oxysterols Metabolism in the Aging Brain
FIGURE 7 | Oxysterols levels in aged wild-type and Egr-1 KO mice hippocampus. Isotope dilution mass spectrometry analysis showing oxysterols levels in
18 months wild-type (WT, black bars) and Egr-1 knock-out (KO, gray bars) mice hippocampus (Hp) expressed as ng/mg of tissue. 7α-HC, 7β-HC, 7-KC, 5α,6α-EC,
5β,6β-EC, 4α-HC, 4β-HC, CT, 5α-OH,6-oxo-CH, 24-HC, 25-HC, 27-HC, 22-hydroxycholesterol (22-HC). Results are presented as the mean ± standard deviation
(n = 6).
with those found in old Egr-1 KO mice brain cortex. Figure 6
shows that in the cortex of old KO mice the oxysterols 7α-HC,
7β-HC; 7-KC, 5α,6α-EC, 5β,6β-EC, CT and 5α-OH,6-oxo-CH
were significantly reduced.
Hippocampal Expression of Egr-1 Is Not
Involved in Oxysterols Metabolism
Finally, given that HO-1 expression does not seem, according to
our data, to be influenced by Egr-1 in the hippocampus, we asked
the question of whether also oxysterol metabolism appeared to
gain independence from Egr-1 control in old mice hippocampus.
As shown in Figure 7, we haven’t registered any significative
change in the content of oxysterols in the hippocampus of aged
mice, though 7α-HC, 7β-HC, 7-KC, 5α,6α-EC and 5β,6β-EC
showed an upward trend.
DISCUSSION
In this study about brain aging, we brought to light a new
regulatory circuit linking the early transcriptional factor Egr-
1 to the brain oxysterol production and accumulation in the
elderly. Moreover, Egr-1, likely by regulating the expression
of HO-1, could have an influence in the accumulation of
oxysterols in the aged brain, specifically in the cortex. The
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FIGURE 8 | Proposed mechanism for oxysterols production in the old mice
brain cortex. High levels of oxidative stress (OS) experienced by the aged
mouse brain cause the phosphorylation of ERK1/2, which induce EGR-1 in
the cortex. EGR-1, in turn, activates HO-1, which regulates oxysterols
metabolism. Specific oxysterols, or a group of them, may maintain and
exacerbate the OS within the brain cortex.
results reported here show the increase in Egr-1, the 32 kDa
heat shock protein HO-1 and oxysterol levels in an age-related
manner in the mouse cortex. These changes do not occur in
the hippocampus area, nor are they observed in the cortex of
age-matched Egr-1 KO mice, highlighting the likely role of Egr-
1 in this process. Egr-1 is a stress-induced early gene and a
transcriptional factor able to regulate the expression of several
genes involved in cell survival, death and proliferation. Several
studies have established an involvement of Egr-1 in synaptic
plasticity and cognitive function, but completely unknown
is whether Egr-1 is involved in their natural decline with
age as well. On the other hand, Egr-1 is implicated in the
development of neurodegenerative disorders, thus becoming a
hallmark for such diseases (Koldamova et al., 2014; Minatohara
et al., 2015; Duclot and Kabbaj, 2017). In AD brains, Egr-1 is
found to be upregulated (Gómez Ravetti et al., 2010), while in
aged mice lacking Egr-1 LTP is impaired (Jones et al., 2001).
The aging brain is constantly exposed to OS, which triggers
and exacerbates brain functional deficit (Uttara et al., 2009).
Oxysterols as a form of oxidized cholesterol are implicated in OS,
in particular the B-ring oxysterols are generated by autoxidation
and by free radical-mediated mechanisms (Iuliano, 2011) and are
regulated by HO-1, an enzyme with a dual function that can be
protective or toxic depending on its levels and context (Chen,
2014).
Based on the above assumptions about the role of Egr-1 in
brain, we wanted to investigate the expression of Egr-1, HO-1
and the levels of oxysterols in the cortex and hippocampus of
adult and old mice, i.e., in an age-dependent fashion, to establish
whether a link could exist between the levels of Egr-1 and OH-1,
and between the level of Egr-1 and the type and amount of
oxysterol accumulated, so to infer about and what consequences
could a change in these levels of Egr-1 and of HO-1 may have
on the accumulation of oxysterols in the same areas. To the
purpose of challenging the effect of Egr-1 on the expression of
HO-1 and oxysterol accumulation, we gathered data from WT
and Egr-1 KO mice and compared the results according to the
area of interest (cortex or hippocampus), and the mouse age (12
or 18 months).
Our data highlight some differences in the regulation of Egr-1
protein expression in the mouse brain cortex and hippocampus in
the aging brain from WT mice. We found that Egr-1 expression
increases in the cortex in an age-dependent fashion. We can only
speculate about the cause behind our evidences. They can be
likely due to a response to the many stress stimuli, including OS,
hypoxia and inflammation that occur in the aged brain. In the
hippocampus, however, Egr-1 does not seem to be under the same
kind of regulation. In fact, we did not observe any significant
change of expression. These data are in agreement with a previous
study showing that Egr-1 levels in the brain do not change with
age in resting mice, but only when they are exposed to a learning
task (Desjardins et al., 1997).
Brain oxysterols are widely accepted markers of OS (Leoni
and Caccia, 2011). Several studies have focused on 24-HC
and 27-HC, which are produced by enzymatic routes and play
an important role in neurodegenerative diseases, Alzheimer’s
included (Bjorkhem et al., 2006; Hughes et al., 2013). For the
first time to our knowledge, we provided a comprehensive
oxysterol profile for the cortex and hippocampus of adult mice.
We showed that distribution and abundance of oxysterols was
different between cortex and hippocampus, and highlighted that
two distinct brain areas, with different functions, have their own
oxysterol composition.
Heme oxygenase-1 is considered a key enzyme for oxysterol
metabolism (Vaya et al., 2007; Hascalovici et al., 2009). In this
context, old mice cortex has increased levels of HO-1 compared
to younger mice. This result is in agreement with other studies
reporting that HO-1 increases with age, is induced by stress
and the high levels correlate with cognitive deficits (Schipper,
1999, 2004; Hirose et al., 2003). Surprisingly, in absence of Egr-1
the expression of HO-1 in the cortex was strongly inhibited
in old mice compared to younger KO mice. This result is in
line with previous observations, although in mouse lung cells
exposed to cigarette smoke, where Egr-1 was able to regulate
HO-1 (Chen et al., 2010). Finally, our data showed that this
signaling may be sustained by the phosphorylation of ERK1/2
in the old brain cortex, which has already been described to be
more activated during aging and to be associated to synaptic
dysfunction (Ogundele et al., 2018). Furthermore, in smooth
muscle cells Egr-1 was demonstrated to be activated via ERK1/2
under OS conditions (Pagel and Deindl, 2012).
Based on our hypothesis, stimulation of HO-1 in the brain
cortex of old mice should result in enhanced oxysterol levels,
whereas deletion of Egr-1 should interfere with this process. In
fact, old WT mice cortex showed higher levels of oxysterols
than the cortex of younger mice but not in the old Egr-1
KO mice which presented much lower oxysterol levels. It is
important to notice that the changes concern mainly those
oxysterols which have been demonstrated to be induced by OS,
i.e., 7α-HC, 7β-HC, 7-KC, 5α,6α-EC and 5β,6β-EC (Iuliano, 2011;
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Mutemberezi et al., 2016). We suggest that oxysterol production
in the aging brain cortex is based on the oxidative induction of
Egr-1 via ERK1/2 phosphorylation, which, in turn, activates HO-
1 (Figure 8). It would be interesting to explore whether a single or
a group of oxysterols may act themselves as a source of OS able to
maintain ERK1/2 in a phosphorylated state and Egr-1 levels high.
Since we have reported the absence of stimulation of Egr-1 and
no difference in ERK1/2 phosphorylation in the hippocampus
of old mice, we finally wanted to examine whether HO-1 and
oxysterols expression was in this case not anymore driven
by an Egr-1-dependent regulation in this brain area. Our
results confirmed that the HO-1 and oxysterol levels were not
significantly different between the hippocampus of adult and of
old WT and Egr-1 KO mice, confirming our hypothesis.
In conclusion, our results show that Egr-1 can be stimulated
in the cortex of old mice suggesting a role in the oxysterol
accumulation by regulating the HO-1 expression. This new
function covered by Egr-1 seems to be brain region-specific
because it is not present in the hippocampus.
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